U.S. drug company Novavax signs deal to supply 76 million doses of possible COVID-19 vaccine to Canada

U.S. drug company Novavax signs deal to supply 76 million doses of possible COVID-19 vaccine to Canada

CBC.ca

Published

Canada's federal government has signed an agreement in principle to acquire up to 76 million doses of a potential COVID-19 vaccine being developed by an American company.

Full Article